{"name":"Glaukos Corporation","slug":"glaukos-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Topical travoprost","genericName":"Topical travoprost","slug":"topical-travoprost","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Topical travoprost","genericName":"Topical travoprost","slug":"topical-travoprost","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQT2RUTUcybzZ1WThCY1doNmhxQmN5b195TTNDQTE2WHhZTEJGMWh0VkZZR0xYdEw3Vk5JX0Y1VlVMcTQtTmVuSnowdjNpRjdGN2podzEwRXRkdE02NG1XUHdDVFJROWhQZWlaZGRTeTlWZFZRaEs2SHEyeFZEUjFGMVpQS2Vna3JtQjRPV0xRaVRkdEw1ZWpieVlB?oc=5","date":"2026-03-12","type":"pipeline","source":"openPR.com","summary":"Presbyopia Pipeline Insight Expands as 10+ Pharma Companies - openPR.com","headline":"Presbyopia Pipeline Insight Expands as 10+ Pharma Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPZWotNjNWbDJjUWJZQ2pZWjQxakJLZFFTUnpFWnNSdU85LS1LSEdwY0RKS2dTV2hRTDFodHNnRGR5REhiX2xEbTZNMVAyWmdwbE5FV1R5bUU1U3c2ek9XWGJodWszaWd6ZWdBYldxeGZUSkVETEZtR0FWVkxpXzZWRm1nZ0VGYzQ3LTJIdWZEVWh4NE1ZU29SaXhCekRabjh3eHY2OXpLU1J0Q3ZfZlE?oc=5","date":"2026-02-18","type":"earnings","source":"BioSpace","summary":"Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results - BioSpace","headline":"Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOLWZVREhpY3V4V2Y3d0NLOTgyVW1ldVVjOF9hXzBDVWl0WFhXQldGRUhJa1JFd3BqLVY4M1RXWjZ4R1hiQ2NiTHBHQ2h3aDhCS1hVRmJULVdiTk85Zlp6ci1sWkxxN3JVUFJGRTBRc0gzeFZ4MWNlVDZoZjl2QU9va1VjRjVWZFJGcmY1WG9sWGJ2UE92OG1ZYTJMUk9RTng2WWYwZDBqSVptZkdoUmJhdDI4WTYxMWNLaTBubjhyMzNObWE2NlFxNEd2ZENlNmtpWHNLWGpybXdxaENyVlQtR3JnbGdOZ0dNZmFXNGNXTXJES2s?oc=5","date":"2026-01-20","type":"earnings","source":"businesswire.com","summary":"Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 - businesswire.com","headline":"Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxORzRlVFZickhOa0Z1YkY1Z0JyeElPcWxvUGluNHFDQWhNVTZUOVI3RUlDdU8xcVJSMVl1WE4wUnd0Wm1YRVNUcGNkOGZQUmc2ZEVDaDVQdmNLMGRLM1RhSG9Jem9Wc1VxSWFLS2ZFaERjUWF4MzYxWmxiU1M5d2JDZ3ZXMXRVOElBdDlkdno4NUF4cXNQUXpkWjlwYUZFSTdsdnJjN1A1cGozTTUyb2U5dEgtRklHaHFfRkp3TFlIcXJuNFBQQW9RdERySkZRaEZ3cDhMN0RxQ3hsRExaVm1BUDAzMnM?oc=5","date":"2026-01-14","type":"pipeline","source":"Benzinga","summary":"Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga","headline":"Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQSHZyMXBQb3lNeTRIRkdxNjNsSk16dEZCeS1rbXEtXzAxNHhfRDFYSnJ0bmFkN2lJZ0JaVFFlbmd1dlZ4Z1ROMGl6blpjWTVOVEpvMXZGZ1JSZWhoR3QxX0Z4M0VjaGFURjJPbWV0SlpqS0xXR09ZeldyTjdUdjFSZmo1eFgzdm1TQjhFTWc4U3M5bWRFOWdOdUFUSlZTMjlaQ0FZd3dRWFZGeHN6MHlBTkl4TUEzMUJsUkpScU9fZjE4Uzg?oc=5","date":"2025-12-16","type":"pipeline","source":"businesswire.com","summary":"Glaukos Announces Participation in J.P. Morgan Healthcare Conference - businesswire.com","headline":"Glaukos Announces Participation in J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPeTV3QVdtVkVCTl8tNDBwLU1na1JReFU1Y2xBeWhDRjA5dzVPZjhncmx4MS1EbEtoeFMxOENmUDlMMTZ2Si1yOW94WjloNWFtdUxNaVJCQWtILWNEZGtlRG1jVnk3QnZiOUF1NTl4eVdxQ0F1MnF6MzZZakxkaTQ4NGMtNF9fOFJjVnRRdGZpeGZKNUtlZnlZemxKNDVPQU0waEhTWUtZUDJ5enFqOHYzWQ?oc=5","date":"2025-10-20","type":"regulatory","source":"Reuters","summary":"US FDA approves Glaukos' new eye therapy - Reuters","headline":"US FDA approves Glaukos' new eye therapy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNYXBuVlNkcHZrc2hSMkhFODFJU09CejJGaU9CLTh1dlZSMHh1UDE4ZV9uNzhELWFoUVdHRkRTdmdkVktrSkU0VjJ6TUxxdUJ4YXN2TExCcG5SbDVSdkdHMGFXQmd4X3VmTzdwSmxPSWs4a3lkNTVVdXRBQm01UU5VWEFmQ3dpLVJ3eWtJRHRpX3ZHbEpEb0lnbkxDdlJBMTc5UEJDMG5qQnJnWGdqcFBWMWQ0bTNBZDVmdmc?oc=5","date":"2025-10-20","type":"regulatory","source":"Pharmaceutical Technology","summary":"FDA approves Glaukos’ Epioxa as incision-free corneal disease treatment - Pharmaceutical Technology","headline":"FDA approves Glaukos’ Epioxa as incision-free corneal disease treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQNHdqUXdlZWJIcU14NWRiZlN6ZnROR29TSHNxZVFFU2FoYk1oMk8wZElBZFdRQjVoN1p6OGVVSWNxc1otbG9qUy1PcTFTWXlPMi1wZ25HcF9mcFpCbngyMVFuZ1NiSHAzbnp6V05NVXpxbnZXcGpFNlhGVTRCLUlGNVp0ZXUzLURrdEtocEZ4Q3c3enU3Y283a1VPZ29Sb0VhdGpoNGVSVHJBOUQyU01z?oc=5","date":"2025-10-07","type":"pipeline","source":"madeinalabama.com","summary":"Glaukos breaks ground on high-tech facility in Huntsville, eyes 150 jobs - madeinalabama.com","headline":"Glaukos breaks ground on high-tech facility in Huntsville, eyes 150 jobs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNT1FGc0E0Vms5TEFRQ2RQSklmSmt3TlpXOVZFcG5vSDdsakpleVIxUWJ4SFJ5R1dSd19tZ2RYRUk3Rlc4TXJDazNidzdZNjFuS1lkeXFjcUZJcHVkb3hOMmFPSzJXdGQxWG1iYldrcDBHSVlQV0JTWnIwa005b1pNaXhINWFOMzU1VDZJQUpsdDNvaGMtWDBZWVpQbTlwWjZxM1RRNFNZUjB6LUxfYWpRUEI3eHhYa3RWZVdoMzktNmdneEt6Wk91UW5MdzE1T1hIcEFycVZWbnZDcnpzNTBVblcwVW5MRDZQZThJRTNFOGVpS3VuSEg4VzlaTWxiS1lpY2MtNFpNcw?oc=5","date":"2025-09-26","type":"pipeline","source":"Business Alabama Magazine","summary":"Glaukos breaks ground on new Huntsville campus - Business Alabama Magazine","headline":"Glaukos breaks ground on new Huntsville campus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQT1hPc1ZuV212NTM2XzBmdWwzX1o2aG5uZXFSRThMQl9Qbmx1Q1REMWx2REEyZC1sZThsQlZmTUlGNzgtWjNfejJWMjFMVGF1eV9ZQ0VzVF9CYTdWRVdETmQ3d2ZzTkducjNmMENHamJYUExOSDdJMEUyeHVPUWVIZnZZSlUyandaUE43WmZHeDNfTDVRT09wVFA3U2lLVHVMQjFUTUhiRThyTUJoMmpBMHAzZw?oc=5","date":"2025-09-25","type":"pipeline","source":"al.com","summary":"Eye care tech company breaks ground on $82M facility in Huntsville - al.com","headline":"Eye care tech company breaks ground on $82M facility in Huntsville","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOUHFKOW5lbEotcVB2X09zQmFNbmtfZTRXNmhuOXpCd2VxSmF5djVYaUxEblpya1ZDOGNRZXZ3UHZENVhvbmRyNW1VajZTNW5Eb185LUtwRTZNTHFBWkxsOWo0TlhEczJHSE4zWXlYbTR6b2JhVi0wM1F3d1Y5NF9IZ2NhamwzU2o3Rm4wcg?oc=5","date":"2025-09-18","type":"regulatory","source":"Yahoo Finance","summary":"Glaukos Corporation (GKOS) Advances Next-Gen Glaucoma and Corneal Therapies, Eyes FDA Approval for Epioxa - Yahoo Finance","headline":"Glaukos Corporation (GKOS) Advances Next-Gen Glaucoma and Corneal Therapies, Eyes FDA Approval for Epioxa","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOUUtGa1h3QXZSczIwcDdiNTVGd1oydGVWRUZvY0lKdHNQV0hQU2ZMeWd1STlmMVM4ZDVVNkptdVZkN3hfOGRySVpXSnlFbk1LUDZzcjZ0UHo2REhkOEF4SUVTR19QcmJfYmpFcjNFVzRWSl9KM1JuRllhSS05S3NpWVdLS3pmZlhDRUNSZ092eWNBM0NNX2xpWEJFVzZtaGJ3bFV5eV9TeXVqVldicEFCLTdsTVBiY195NjQ0dzZ1RS1wZUd4enJsZ1doc2tZMnBmSjltWkxfelJKVG83T2YzMmRpenpwR2ZFZndHZlE0blpoMl9aTnRNZzNR?oc=5","date":"2024-12-19","type":"pipeline","source":"City of Huntsville (.gov)","summary":"Global ophthalmic pharmaceutical and medical technology company, Glaukos, to locate multimillion-dollar facility in Cummings Research Park - City of Huntsville (.gov)","headline":"Global ophthalmic pharmaceutical and medical technology company, Glaukos, to locate multimillion-dollar facility in Cumm","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}